Biotechnology Focus senior writer Shawn Lawrence goes one-on-one with Mike Woollatt, chief executive officer of the Canadian Venture Capital & Private Equity Association (CVCA), to discuss the upswing of venture capital investment in Canada, and to find out just  how much is going to Canadian biotech and life science companies.

Biotechnology Focus senior writer Shawn Lawrence goes one-on-one with Mike Woollatt, chief executive officer of the Canadian Venture Capital & Private Equity Association (CVCA), to discuss the upswing of venture capital investment in Canada, and to find out just how much is going to Canadian biotech and life science companies.

Biotechnology Focus senior writer Shawn Lawrence goes one-on-one with&nbsp;Mike Woollatt, chief executive officer of the Canadian Venture Capital &amp; Private Equity Association (CVCA), to discuss the upswing of venture capital investment in Canada, and to find out just&nbsp; how much is going to Canadian biotech and life science companies.

023: VC money starts flowing into Canada, but how big is biotech's piece of the action?

On the Biotechnology Focus Podcast we bring you the latest news, insights, and interviews from Canada's Biotechnology sector.

Share 023: VC money starts flowing into Canada, but how big is biotech's piece of the action?

Sign up to save your podcasts

023: VC money starts flowing into Canada, but how big is biotech's piece of the action?

023: VC money starts flowing into Canada, but how big is biotech's piece of the action?